269 related articles for article (PubMed ID: 22442201)
1. Antielastin B-cell and T-cell immunity in patients with chronic obstructive pulmonary disease.
Rinaldi M; Lehouck A; Heulens N; Lavend'homme R; Carlier V; Saint-Remy JM; Decramer M; Gayan-Ramirez G; Janssens W
Thorax; 2012 Aug; 67(8):694-700. PubMed ID: 22442201
[TBL] [Abstract][Full Text] [Related]
2. Antielastin autoimmunity in tobacco smoking-induced emphysema.
Lee SH; Goswami S; Grudo A; Song LZ; Bandi V; Goodnight-White S; Green L; Hacken-Bitar J; Huh J; Bakaeen F; Coxson HO; Cogswell S; Storness-Bliss C; Corry DB; Kheradmand F
Nat Med; 2007 May; 13(5):567-9. PubMed ID: 17450149
[TBL] [Abstract][Full Text] [Related]
3. Anti-proline-glycine-proline or antielastin autoantibodies are not evident in chronic inflammatory lung disease.
Greene CM; Low TB; O'Neill SJ; McElvaney NG
Am J Respir Crit Care Med; 2010 Jan; 181(1):31-5. PubMed ID: 19762563
[TBL] [Abstract][Full Text] [Related]
4. Systemic CD4+ T-cell activation is correlated with FEV1 in smokers.
Glader P; von Wachenfeldt K; Löfdahl CG
Respir Med; 2006 Jun; 100(6):1088-93. PubMed ID: 16246539
[TBL] [Abstract][Full Text] [Related]
5. Influence of smoking cessation on airway T lymphocyte subsets in COPD.
Roos-Engstrand E; Ekstrand-Hammarström B; Pourazar J; Behndig AF; Bucht A; Blomberg A
COPD; 2009 Apr; 6(2):112-20. PubMed ID: 19378224
[TBL] [Abstract][Full Text] [Related]
6. The search for autoantibodies against elastin, collagen and decorin in COPD.
Brandsma CA; Kerstjens HA; Geerlings M; Kerkhof M; Hylkema MN; Postma DS; Timens W
Eur Respir J; 2011 May; 37(5):1289-92. PubMed ID: 21532021
[No Abstract] [Full Text] [Related]
7. Increased intraepithelial T-cells in stable COPD.
Löfdahl MJ; Roos-Engstrand E; Pourazar J; Bucht A; Dahlen B; Elmberger G; Blomberg A; Sköld CM
Respir Med; 2008 Dec; 102(12):1812-8. PubMed ID: 18706796
[TBL] [Abstract][Full Text] [Related]
8. Antinuclear autoantibodies are more prevalent in COPD in association with low body mass index but not with smoking history.
Bonarius HP; Brandsma CA; Kerstjens HA; Koerts JA; Kerkhof M; Nizankowska-Mogilnicka E; Roozendaal C; Postma DS; Timens W
Thorax; 2011 Feb; 66(2):101-7. PubMed ID: 21047865
[TBL] [Abstract][Full Text] [Related]
9. Differential switching to IgG and IgA in active smoking COPD patients and healthy controls.
Brandsma CA; Kerstjens HA; van Geffen WH; Geerlings M; Postma DS; Hylkema MN; Timens W
Eur Respir J; 2012 Aug; 40(2):313-21. PubMed ID: 22241744
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking.
Barceló B; Pons J; Ferrer JM; Sauleda J; Fuster A; Agustí AG
Eur Respir J; 2008 Mar; 31(3):555-62. PubMed ID: 18057064
[TBL] [Abstract][Full Text] [Related]
11. A novel insight into adaptive immunity in chronic obstructive pulmonary disease: B cell activating factor belonging to the tumor necrosis factor family.
Polverino F; Baraldo S; Bazzan E; Agostini S; Turato G; Lunardi F; Balestro E; Damin M; Papi A; Maestrelli P; Calabrese F; Saetta M
Am J Respir Crit Care Med; 2010 Oct; 182(8):1011-9. PubMed ID: 20581172
[TBL] [Abstract][Full Text] [Related]
12. Distribution of γδ and other T-lymphocyte subsets in patients with chronic obstructive pulmonary disease and asthma.
Urboniene D; Babusyte A; Lötvall J; Sakalauskas R; Sitkauskiene B
Respir Med; 2013 Mar; 107(3):413-23. PubMed ID: 23273406
[TBL] [Abstract][Full Text] [Related]
13. Elastin-Specific Autoimmunity in Smokers With Thoracic Aortic Aneurysm and Dissection is Independent of Chronic Obstructive Pulmonary Disease.
Gu BH; Choi JC; Shen YH; Song LZ; Scheurer ME; Luong A; Rodriguez A; Woodruff P; Koth L; Corry DB; Kheradmand F; LeMaire SA
J Am Heart Assoc; 2019 Apr; 8(8):e011671. PubMed ID: 30957625
[TBL] [Abstract][Full Text] [Related]
14. Increased proportion of Fas positive CD8+ cells in peripheral blood of patients with COPD.
Domagała-Kulawik J; Hoser G; Dabrowska M; Chazan R
Respir Med; 2007 Jun; 101(6):1338-43. PubMed ID: 17118637
[TBL] [Abstract][Full Text] [Related]
15. Impaired systemic cell-mediated immunity and increased susceptibility to acute respiratory tract infections in patients with COPD.
Takabatake N; Sata M; Abe S; Inoue S; Saito H; Yuki H; Shibata Y; Kubota I
Respir Med; 2005 Apr; 99(4):485-92. PubMed ID: 15763456
[TBL] [Abstract][Full Text] [Related]
16. Lung tissue and tumour-infiltrating T lymphocytes in patients with non-small cell lung carcinoma and chronic obstructive pulmonary disease (COPD): moderate/severe versus mild stage of COPD.
Marc MM; Korosec P; Kern I; Sok M; Ihan A; Kosnik M
Scand J Immunol; 2007 Dec; 66(6):694-702. PubMed ID: 17949407
[TBL] [Abstract][Full Text] [Related]
17. The expression of Foxp3 and ROR gamma t in lung tissues from normal smokers and chronic obstructive pulmonary disease patients.
Chu S; Zhong X; Zhang J; Lao Q; He Z; Bai J
Int Immunopharmacol; 2011 Nov; 11(11):1780-8. PubMed ID: 21791252
[TBL] [Abstract][Full Text] [Related]
18. Relation between duration of smoking cessation and bronchial inflammation in COPD.
Lapperre TS; Postma DS; Gosman MM; Snoeck-Stroband JB; ten Hacken NH; Hiemstra PS; Timens W; Sterk PJ; Mauad T
Thorax; 2006 Feb; 61(2):115-21. PubMed ID: 16055612
[TBL] [Abstract][Full Text] [Related]
19. Imbalance between subpopulations of regulatory T cells in COPD.
Hou J; Sun Y; Hao Y; Zhuo J; Liu X; Bai P; Han J; Zheng X; Zeng H
Thorax; 2013 Dec; 68(12):1131-9. PubMed ID: 23749814
[TBL] [Abstract][Full Text] [Related]
20. Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers.
Shaker SB; von Wachenfeldt KA; Larsson S; Mile I; Persdotter S; Dahlbäck M; Broberg P; Stoel B; Bach KS; Hestad M; Fehniger TE; Dirksen A
Clin Respir J; 2008 Jan; 2(1):17-25. PubMed ID: 20298300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
